Skip to Main Content

Substance Abuse & Addiction Medicine

Tulane - Division of Addiction Medicine & Addiction Medicine Fellowship

ASAM Guidelines

ASAM Clinical Guidelines
The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use ( Adopted by the ASAM Board of Directors June 1, 2015)
Journal of Addiction Medicine [ISSN: 1932-0620]
Journals@Ovid (Tulane license)

more... less...

2.699 - 2018 Journal Impact Factor

IMPORTANT GUIDELINES

U.S. Department of Health and Human Services Working Group on Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. (O
IMPORTANT: HHS OPIOID TAPERING GUIDELINES (PDF Document)

Medication-Assisted Treatment (MAT) - Key information from SAMHSA

Programs ⁄ Medication-Assisted Treatment (MAT)
SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

AMHCA - Policy on Integration of Mental Health and Primary Care Services

AMHCA White Paper Publications Integration of Mental Health and Primary Care Services
Download from: American Mental Health Counselors Association. https://www.amhca.org

AlosaHealth.

Helping patients manage opioid use disorder: Identifying and treating opioid addiction.
Principal Consultant: Rachel Barenie, PharmD, JD, MPH- © 2019 Alosa Health.

more... less...

These are general recommendations only; specific clinical decisions should be
made by the treating clinician based on an individual patient’s clinical condition.

HHS. Naloxone

HHS recommends prescribing or co-prescribing naloxone to patients at high risk for an opioid overdose

Last Updated: Jun 16, 2025 3:16 PM
URL: https://libguides.tulane.edu/SubstanceAbuse
Print Page

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.